Physician

Calvin Reed Fesler, MD

According to 2025 Medicare claims, Calvin Fesler, MD (NPI: 1285169136) practices pain management in the Cleveland, TN market, with the plurality of this provider's patient population coming from Bradley, TN. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP TENNESSEE LLC (NPI: 1376110858; TIN: 85-1230024) and primary practice location at 37312-4840. Fesler is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Fesler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 231 traditional Medicare patients, billed 3,447 HCPCS/CPT codes, and received $110,677 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,117 prescription claims across 609 beneficiaries totaling $144,831 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 28 records totaling $569. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$55K$111K2023 Medicare payment: $57,747 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $110,677 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231761,853$57,747
20242313,447$110,677

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$72K$145K2021 Drug cost: $10,854 (USD; Tot_Drug_Cst)2022 Drug cost: $25,340 (USD; Tot_Drug_Cst)2023 Drug cost: $61,842 (USD; Tot_Drug_Cst)2024 Drug cost: $144,831 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202134131$10,854
2022225713$25,340
20234781,746$61,842
20246093,117$144,831

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6767$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more180582$85
80307Testing for presence of drug, by chemistry analyzers124214$60
96127Assessment of emotional or behavioral problems97104$3
J1100Injection, dexamethasone sodium phosphate, 1 mg47668$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl601,800$34,518
BuprenorphineBuprenorphine621,736$20,435
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64518,288$17,952
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54115,078$16,285
GabapentinGabapentin46113,897$6,059

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$569Collegium Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Calvin Reed Fesler, MD?

Tedicare shows public-source Medicare data for Calvin Reed Fesler, MD (NPI 1285169136), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Calvin Reed Fesler, MD have ACO affiliation data?

Calvin Reed Fesler, MD is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Calvin Reed Fesler, MD?

Calvin Reed Fesler, MD is linked to PRIVIA MEDICAL GROUP TENNESSEE LLC (billing NPI 1376110858) in the available physician profile data.

Does Calvin Reed Fesler, MD have Open Payments data?

Calvin Reed Fesler, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.